Argus Research raises Regeneron Pharmaceuticals to buy from hold
REGN•Argus Research raised its rating on Regeneron Pharmaceuticals to buy from hold.
Related News
Canada research roundup: Air Canada, Dye & Durham Limited, Onex Corporation
EWC•
United Airlines: Jefferies cuts target price to $134 from $155
UAL•
Vicor Corporation: Needham raises target price to $350 from $320
VICR•
Brightline Interactive closes $1.25 million PIPE financing led by Allan Evans
BTLN•
InflaRx appoints Gabriela Alperovich as SVP, global head of clinical development
IFRX•